跳至主要内容
临床试验/NCT03486262
NCT03486262Unknown不适用

Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Molecular profile of IPF-associated lung carcinomas

研究概览

简要总结

Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary fibrosis, diagnosed and / or treated in participating centers. The cases are recovered retrospectively from the records of the pulmonology and pathology departments of our various partners.

详细描述

Primary objective:

Characterize altered molecular pathways in lung cancer in patients with IPF versus lung cancer in non-IPF patients.

Secondary objectives:

Identify specific therapeutic targets Describe a cohort of lung cancers on IPF (clinical / radiological and pathological data) To study the relationship between neoplastic / preneoplastic lesions and pulmonary parenchyma reshaped by fibrosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Lung carcinoma
  • Idiopathic pulmonary fibrosis

排除标准

  • No tumor sample available

结局指标

主要结局

Molecular profile of IPF-associated lung carcinomas

时间窗: 1 month / 8 samples

Next generation sequencing of carcinomas with Ion S5 XL sequencer and Oncomine™ Comprehensive Panel

次要结局

  • Pathological characterization of lung carcinomas(1 month / 8 samples)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验